Alexion Charitable Foundation (ACF)

Alexion Charitable Foundation (ACF)

General
Jobs 0
Shortlists/Awards 0
Pricing strategy 0
Partners/Competitors 0
Last update: Apr 14, 2025 Last update: Apr 14, 2025
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors

Details

Legal residence:USA
Organization type:Grant-making Foundation / Charity
Funding agencies:Other
Other
Sectors:Education, Health, Research
Education, Health, Research
Nr. of employees:1001-5000
Sanctions:Check now
Status:
Active

Attachments 0

About

Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs.

Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.

Top partners

Top competitors

Want to unlock full information?
Register with us or sign in to access the organization database.